Publications Office of the EU
Dostawa leków onkologicznych. - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Dostawa leków onkologicznych.

Overview
  • Published
    03/02/2025
  • Deadline
    17/02/2025
  • Opening of tenders
    17/02/2025
  • Today
    26/03/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL814 Lubelski
Business sector (Main CPV)
33690000 Various medicinal products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
65
Procedure details
Tender reference number
COZL/DZP/AK/3411/PN-177/24
Description

Przedmiotem zamówienia jest: Dostawa leków onkologicznych. Zamówienie zostało podzielone na 65 części.

Submission Method
Electronic via:
https://platformazakupowa.pl/transakcja/1037618
Tenders may be submitted
Electronic submission: required
https://platformazakupowa.pl/transakcja/1037618
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
17/02/2025 09:00
Place of performance
PL814 Lubelski
PL Polska
CPV code

33690000 - Various medicinal products

Lots (65)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.